Macro Group Pharmaceuticals (Macro Capital) S.A.E reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EGP 729.61 million compared to EGP 594.26 million a year ago. Net income was EGP 173.84 million compared to EGP 147.93 million a year ago.

Basic earnings per share from continuing operations was EGP 0.3 compared to EGP 0.26 a year ago. Diluted earnings per share from continuing operations was EGP 0.3 compared to EGP 0.26 a year ago.